Differences in utilization of asthma drugs between two neighbouring Swedish provinces : relation to treatment in individuals with airway disease.
To assess the extent to which drugs were used by individuals found to have asthma in a population survey.
To assess the relative influence of the proportion of patients treated and doses reported on the sales of drugs.
To study if observed differences in sales of asthma drugs between the county of Jämtland (with high sales) and Gävleborg (with lower sales) correlated to a difference in the control of the disease.
A cross-sectional population study with a postal questionnaire followed by an interview and examination of symptomatic individuals.
Asthma was diagnosed in subjects reporting a typical history of asthma or repeated episodes of dyspnoea and wheezing, or dry cough combined with reversibility in FEV1, PEF-variability or PC20 ¾ 4 mg ml-1.
The county of Jämtland, and Gästrikland, a southern part of the county of Gävleborg in central Sweden.
Drug use and symptoms reported by individuals found to have asthma or chronic obstructive pulmonary disease (COPD).
Inhaled bêta2 agonists and inhaled steroids were used more often by individuals with asthma and COPD in Jämtland.
However, regular use was more common in Gävleborg.
Most of the asthmatics did not use any medication in spite of the fact that symptoms were commonly reported.
The drug combinations most often used were inhaled bêta2 agonists alone or in combination with inhaled steroids.
Mots-clés Pascal : Asthme, Chimiothérapie, Epidémiologie, Suède, Europe, Traitement, Homme, Appareil respiratoire pathologie, Bronchopneumopathie obstructive
Mots-clés Pascal anglais : Asthma, Chemotherapy, Epidemiology, Sweden, Europe, Treatment, Human, Respiratory disease, Obstructive pulmonary disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0015166
Code Inist : 002B11B. Création : 01/03/1996.